Naftopidil

Spécifications

57149-07-2Numéro CAS

692-531-5Numéro CE

1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-olNom IUPAC

C24H28N2O3Formule chimique

392.5 g/molMasse molaire

naftopidil; 57149-07-2; Flivas; Naftopidilum; DTXSID5045176; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; R9PHW59SFN; NSC-759293; DTXCID3025176; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol; 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 1-[4-(2-Methoxyphenyl)-1-piperazinyl]-3-(1-naphthyloxy)-2-propanol; RefChem:831691; (2RS)-1-(4-(2-Methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; Avishot; Naftopidil [INN]; KT-611; 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; (+/-)-Naftopidil; MFCD00242741; BM-15275; CHEMBL142635; NCGC00015718-06; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol; Naftopidilum [Latin]; SMR000466346; CAS-57149-07-2; UNII-R9PHW59SFN; BRN 0629965; Avishot;; Flivas (TN); Naftopidil (Standard); NAFTOPIDIL [MI]; NAFTOPIDIL [JAN]; Prestwick0_000975; Prestwick1_000975; Prestwick2_000975; Prestwick3_000975; (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol; Naftopidil (JP18/INN); (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol; cid_4418; NAFTOPIDIL [MART.]; NAFTOPIDIL [WHO-DD]; Lopac0_000941; REGID_for_CID_4418; BSPBio_001009; MLS000759459; MLS001424117; orb134855; SCHEMBL113215; SPBio_002920; BPBio1_001111; Naftopidil - Bio-X trade mark; orb1224628; orb1310376; SCHEMBL29449978; BDBM50773; CHEBI:31891; cid_6603044; HY-B0391R; HMS2051B09; HMS2089G07; HMS3393B09; HMS3655H21; HMS3884P07; HMS5080K14; Pharmakon1600-01506024; HY-B0391; Tox21_110205; EBC-03851; MFCD11046013; MSK163437; NSC759293; s2126; STL372645; (+-)-4-(o-Methoxyphenyl)-alpha-((1-naphthyloxy)methyl)-1-piperazineethanol; 1-Pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-; AKOS002279617; AKOS016328058; Tox21_110205_1; CCG-100935; CCG-205022; DB12092; FE-0209; FN26123; NC00185; NSC 759293; SB19321; SDCCGSBI-0050915.P003; NCGC00015718-04; NCGC00015718-05; NCGC00015718-08; NCGC00015718-09; NCGC00015718-10; NCGC00015718-12; NCGC00015718-22; NCGC00015718-25; NCGC00024672-03; NCGC00024672-04; BN164631; SY053735; SBI-0050915.P002; AB00514643; N0123; N0832; ST50794017; SW196570-4; T0696; D01674; AB00489961-18; AB00489961-19; AB00489961_20; AB00489961_21; EN300-6492981; F463444; Q6958243; BRD-A01787639-001-06-4; BRD-A01787639-001-07-2; BRD-A01787639-001-08-0; BRD-A01787639-003-16-9; BRD-A01787639-300-03-7; BRD-A01787639-300-04-5; BRD-A01787639-300-08-6; BRD-A01787639-300-09-4; Z31369389; 1-[4-(2-methoxyphenyl)piperazinyl]-3-naphthyloxypropan-2-ol; 1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol; 1-[4-(2-methoxyphenyl)piperazino]-3-(1-naphthoxy)propan-2-ol;hydrochloride; 4-(2-Methoxyphenyl)-?-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; (+/-)-4-(O-METHOXYPHENYL)-.ALPHA.-((1-NAPHTHYLOXY)METHYL)-1-PIPERAZINEETHANOL; 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthalenyloxy)-2-propanol;hydrochloride; 1-[4-(2-Methoxyphenyl)piperazin-1-yl]-3-[(naphthalen-1-yl)oxy]propan-2-ol; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxy-propan-2-ol;hydrochloride; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;hydrochloride; 4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol hydrochloride hydrateSynonymes